Novo expanding massive Denmark plant

kalundborg
An aerial image of Novo Nordisk's Kalundborg site, courtesy of Novo Nordisk.

Just weeks after kicking off construction of a nearly $2 billion API plant in the U.S., Novo Nordisk ($NVO) will also expand a facility in Denmark that it says is the world’s largest insulin plant.

The Danish drugmaker will spend $59.70 million (400 million Danish kroner) on a 500 meter (5,381 foot) expansion of the facility in Kalundborg. The expansion is set to be complete in 2018.

Novo said the 1.1-million-square-meter (11.8-million-square-foot) plant currently has 3,400 employees and produces 50% of the world's insulin.

Conference

The 13th Annual Digital Pharma East

Digital Pharma East returns to the Pennsylvania Convention Center September 17–20, bringing together over 1000 attendees from biotech and pharma, to better understand how to present business plans, justify budget and innovation, and de-risk proposals getting shut down — essentially, understand how they can return to the office and become champions for their internal digital needs. Join us and save 15% on standard rates when you register with Discount Code DPE19Fierce.

“The new facilities will give us greater flexibility and enable the installation of equipment that will enhance efficiency and increase the long-term production capacity of the plant," Michael Hallgren, senior VP and head of production in Kalundborg, said in a statement.

At the end of March, Novo kicked off construction of its first U.S. insulin API plant, an $1.8 billion project in Clayton, NC. That facility will have a footprint of 417,639 square feet, which it said equates to about 7 football fields. It is slated to have 700 employees when complete in 2020.

- read the announcement 

Related Articles:
Novo starts construction on $1.8B plant in U.S. 
Novo picks Clayton, NC, for its first U.S. API plant

Read more on

Suggested Articles

Novartis' AveXis will use Catalent for some manufacturing of its newly approved gene therapy Zolgensma and more manufacturing news of note.

Pharmacy chain Rite Aid has partnered with Google to have their drug recycling stations easily searchable on Google Maps. 

Precision BioSciences says it will have a manufacturing facility for its off-the-shelf CAR-T therapies up and running in the fourth quarter.